253 related articles for article (PubMed ID: 21440359)
1. Trichomoniasis: evaluation to execution.
Harp DF; Chowdhury I
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359
[TBL] [Abstract][Full Text] [Related]
2. Trichomoniasis and its treatment.
Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
[TBL] [Abstract][Full Text] [Related]
3. Premature with trichomoniasis: report of one case.
Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
[TBL] [Abstract][Full Text] [Related]
4. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
5. Trichomoniasis. An update on diagnostic tools and treatments.
Reyes M
Adv Nurse Pract; 2008 Apr; 16(4):69-70, 72. PubMed ID: 19999494
[No Abstract] [Full Text] [Related]
6. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
7. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
10. Intestinal and urogenital flagellates.
Meingassner JG; Heyworth PG
Antibiot Chemother (1971); 1981; 30():163-202. PubMed ID: 7259131
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
12. Trichomoniasis.
Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
[TBL] [Abstract][Full Text] [Related]
13. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
14. Antitrichomonal action of emodin in mice.
Wang HH
J Ethnopharmacol; 1993 Oct; 40(2):111-6. PubMed ID: 8133650
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of polysaccharide and glycoprotein fractions of Trichomonas vaginalis in the serodiagnosis of Trichomonas infections].
Małyszko E; Januszko T; Ustymowicz-Farbiszewska J; Czapska D
Wiad Parazytol; 1991; 37(2):225-33. PubMed ID: 1822039
[TBL] [Abstract][Full Text] [Related]
16. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
17. Nitroimidazole Resistance in Trichomonas vaginalis Infection: A Teachable Moment.
Salas A; Hamill MM; Tuddenham S
JAMA Intern Med; 2019 Feb; 179(2):247-248. PubMed ID: 30575848
[No Abstract] [Full Text] [Related]
18. Clinical and microbiological aspects of Trichomonas vaginalis.
Petrin D; Delgaty K; Bhatt R; Garber G
Clin Microbiol Rev; 1998 Apr; 11(2):300-17. PubMed ID: 9564565
[TBL] [Abstract][Full Text] [Related]
19. Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis.
Edwards T; Burke P; Smalley H; Hobbs G
Crit Rev Microbiol; 2016 May; 42(3):406-17. PubMed ID: 25383648
[TBL] [Abstract][Full Text] [Related]
20. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
